Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × lenvatinib × Sarcoma × Clear all

Phase

Status

Completed 4 Withdrawn 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 54 Genitourinary 8 Gynecologic 7 Thoracic 6 Other solid neoplasm 5 Head & Neck 5 Breast 5 Endocrine 3 Tumor-Agnostic 2 Sarcoma 1 Other hematologic neoplasm 1 NET 1 CNS 1

Conditions

Interventions

Doxorubicin 23 Cyclophosphamide 19 Specimen Handling 18 pembrolizumab 16 Temozolomide 14 Biopsy 14 Gemcitabine 13 Magnetic Resonance Spectroscopy 11 Blood Specimen Collection 11 fludarabine 10 atezolizumab 10 Surgical Procedures, Operative 10 Radiotherapy 10 Vincristine 8 Ifosfamide 8 Drug Therapy 8 Trabectedin 7 Nivolumab 7 Surveys and Questionnaires 6 Radiation 6 Imatinib Mesylate 6 cabozantinib 5 Standard of Care 5 Radiation Dose Hypofractionation 5 Irinotecan 5 Dactinomycin 5 selinexor 4 liposomal doxorubicin 4 irinotecan sucrosofate 4 fludarabine phosphate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07359053 2026-01-22

MAGNATE-S

Shanghai 6th People's Hospital

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡